Quest Diagnostics Inc (DGX)-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014252)
◆英語タイトル:Quest Diagnostics Inc (DGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014252
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:74
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology. It also provides diagnostic products. The company offers these services to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. The company is headquartered in Madison, New Jersey, the US.

Quest Diagnostics Inc (DGX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Quest Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Devices Deals, 2011 to YTD 2017 10
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Quest Diagnostics Acquires Lab Outreach Service Business of Clinical Laboratory Partners 13
Quest Diagnostics Acquires Lab Outreach Service Business from Memorial Care Health System 14
Quest Diagnostics Acquires Outreach Laboratory Service Operations from Steward Health Care System 15
Quest Diagnostics Completes Acquisition Of Lab-Related Clinical Outreach Operations Of Dignity Health 16
Quest Diagnostics Acquires Advanced Toxicology Network Lab Business Of Concentra Operating 18
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 19
Partnerships 20
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 20
Quintiles to Form Joint Venture with Quest Diagnostics 22
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 23
Quest Diagnostics Enters Into Collaboration With Genomic Vision 24
Licensing Agreements 25
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 25
Debt Offering 26
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 26
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 28
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 30
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 32
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 33
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 34
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 35
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 36
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 37
Asset Transactions 38
Royalty Pharma Acquires Ibrutinib Royalty Rights From Quest Diagnostics For US$485 Million 38
Acquisition 39
Quest Diagnostics May Sell itself 39
Quest Diagnostics Completes Acquisition Of Summit Health, Prevention And Wellness Service Provider 40
Quest Diagnostics Completes Acquisition Of Solstas Lab Partners From Welsh, Carson, Anderson & Stowe For US$570 Million 41
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 42
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 43
Quest Diagnostics Completes Acquisition Of Celera 44
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 46
Quest Diagnostics Inc – Key Competitors 48
Quest Diagnostics Inc – Key Employees 49
Quest Diagnostics Inc – Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Joint Venture 53
Recent Developments 54
Financial Announcements 54
Oct 19, 2017: Quest Diagnostics Reports Third Quarter 2017 Financial Results 54
Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 55
Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook 56
Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 57
Nov 11, 2016: Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day 58
Oct 20, 2016: Quest Diagnostics Reports Third Quarter 2016 Financial Results 59
Jul 21, 2016: Quest Diagnostics Reports Second Quarter 2016 Financial Results 61
Apr 21, 2016: Quest Diagnostics Reports First Quarter 2016 Financial Results 63
Jan 28, 2016: Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For Full Year 2016; Increases Dividend 5% To $0.40 Per Quarter 64
Corporate Communications 65
Mar 06, 2017: Quest Diagnostics and American Diabetes Association to Help Identify People at Risk for Type 2 Diabetes 65
Dec 15, 2016: Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board 66
Legal and Regulatory 67
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 67
Government and Public Interest 68
Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests 68
Sep 06, 2017: Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis 69
Other Significant Developments 71
Sep 27, 2017: Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes 71
Oct 18, 2016: IBM and Quest Diagnostics Launch Watson-Powered Genomic Sequencing Service to Help Physicians Bring Precision Cancer Treatments to Patients Nationwide 72
Appendix 74
Methodology 74
About GlobalData 74
Contact Us 74
Disclaimer 74

List of Tables
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Quest Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Quest Diagnostics Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Devices Deals, 2011 to YTD 2017 10
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Quest Diagnostics Acquires Lab Outreach Service Business of Clinical Laboratory Partners 13
Quest Diagnostics Acquires Lab Outreach Service Business from Memorial Care Health System 14
Quest Diagnostics Acquires Outreach Laboratory Service Operations from Steward Health Care System 15
Quest Diagnostics Completes Acquisition Of Lab-Related Clinical Outreach Operations Of Dignity Health 16
Quest Diagnostics Acquires Advanced Toxicology Network Lab Business Of Concentra Operating 18
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 19
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 20
Quintiles to Form Joint Venture with Quest Diagnostics 22
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 23
Quest Diagnostics Enters Into Collaboration With Genomic Vision 24
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 25
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 26
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 28
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 30
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 32
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 33
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 34
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 35
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 36
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 37
Royalty Pharma Acquires Ibrutinib Royalty Rights From Quest Diagnostics For US$485 Million 38
Quest Diagnostics May Sell itself 39
Quest Diagnostics Completes Acquisition Of Summit Health, Prevention And Wellness Service Provider 40
Quest Diagnostics Completes Acquisition Of Solstas Lab Partners From Welsh, Carson, Anderson & Stowe For US$570 Million 41
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 42
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 43
Quest Diagnostics Completes Acquisition Of Celera 44
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 46
Quest Diagnostics Inc, Key Competitors 48
Quest Diagnostics Inc, Key Employees 49
Quest Diagnostics Inc, Subsidiaries 51
Quest Diagnostics Inc, Joint Venture 53

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Quest Diagnostics Inc (DGX)-製薬・医療分野:企業M&A・提携分析(Quest Diagnostics Inc (DGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆